Neuland Laboratories share news, announcements and annual reports
NSE: NEULANDLABBSE: 524558Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 27 Oct 2026. Previous close ₹19,055.00.
27 Oct: open ₹19,055.00, high ₹19,485.00, low ₹19,055.00
- Next results date: the board meets on 3 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹24,781 Cr356th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 49.78
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 13.22
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.18%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 29.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 32.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.10
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 22,94443.0% delivered
Neuland Laboratories share news and announcements
837 announcements, routine notices left out, newest first. Page 2 of 17.
Dec 2025
8 Dec · Updates
Nov 2025
28 Nov · General Updates
21 Nov · Updates
Oct 2025
28 Oct · Analysts
17 Oct · Updates
6 Oct · Meeting
Sep 2025
23 Sep · General Updates
17 Sep · Updates
10 Sep · Updates
Aug 2025
30 Aug · Issue of Duplicate Share Certificate
30 Aug · General Updates
26 Aug · Meeting
23 Aug · Updates
20 Aug · Analysts
5 Aug · Analysts
Jul 2025
31 Jul · Results
23 Jul · Addendum
15 Jul · Analysts
15 Jul · Updates
14 Jul · Board meeting
4 Jul · Meeting
Jun 2025
28 Jun
21 Jun · Rating
19 Jun · Analysts
11 Jun · Analysts
May 2025
15 May
15 May · Corporate action
15 May · Management
15 May · Results
7 May · Retirement